Is Glanzmanns thrombasthenia hereditary?

Glanzmann’s thrombasthenia is a rare, inherited blood clotting disorder caused by mutations in the ITGA2B or ITB3 genes. It follows an autosomal recessive inheritance pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to manifest the condition.

Is Glanzmann’s thrombasthenia strictly hereditary?

Yes, Glanzmann’s thrombasthenia is a strictly genetic and hereditary condition. While the term "genetic" refers to the presence of a mutation in the DNA, "hereditary" specifically refers to the transmission of these mutations from parents to offspring. Because it is an autosomal recessive disorder, it is not passed through X-linked or mitochondrial pathways. It is extremely rare for Glanzmann’s thrombasthenia to arise from a de novo (spontaneous) mutation; in the vast majority of cases, the condition is inherited from parents who are asymptomatic carriers.

How is Glanzmann’s thrombasthenia inherited?

The inheritance of Glanzmann’s thrombasthenia follows an autosomal recessive pattern. This means that both parents of an affected child are typically carriers, possessing one functional gene and one mutated gene. Because these parents are carriers, they generally do not show symptoms of the disease. When two carriers conceive, the risk for each pregnancy follows these statistical probabilities:

• 25% chance the child will have Glanzmann’s thrombasthenia (inheriting two mutated genes).


• 50% chance the child will be an asymptomatic carrier (inheriting one mutated gene).


• 25% chance the child will inherit two healthy genes and be neither affected nor a carrier.

When is genetic testing recommended for Glanzmann’s thrombasthenia?

Genetic testing is the definitive method for confirming a diagnosis of Glanzmann’s thrombasthenia. It is recommended when a patient presents with a history of lifelong mucosal bleeding, such as frequent nosebleeds (epistaxis), gum bleeding, or heavy menstrual periods, alongside normal platelet counts but abnormal platelet aggregation studies. Molecular genetic testing identifies specific variants in the ITGA2B or ITB3 genes, which encode the GPIIb/IIIa complex. Identifying the specific mutation is vital not only for clinical diagnosis but also for family planning and determining the risk of recurrence in future pregnancies.

What is the role of genetic counseling for affected families?

Genetic counseling is a cornerstone of care for families impacted by Glanzmann’s thrombasthenia. A genetic counselor can help families understand the inheritance risks, interpret complex test results, and discuss reproductive options. For those planning a family, options such as prenatal diagnosis (via chorionic villus sampling or amniocentesis) or preimplantation genetic testing (PGT) may be discussed. Our DiseaseMaps.org community, which includes 59 members living with Glanzmann’s thrombasthenia, provides a space to share experiences regarding these deeply personal genetic decisions and the daily management of the condition.

Next steps

• Consult with a hematologist specializing in rare bleeding disorders to discuss clinical management.


• Request a referral to a certified genetic counselor to map out family inheritance risks.


• Join the DiseaseMaps.org community to connect with others who understand the diagnostic journey of Glanzmann’s thrombasthenia.


• Ensure all family members are aware of their carrier status if the family mutation has been identified.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Glanzmann thrombasthenia.


• Orphanet: Glanzmann thrombasthenia (ORPHA:837).


• OMIM (Online Mendelian Inheritance in Man): Thrombasthenia of Glanzmann and Naegeli (Entry #273800).


• National Hemophilia Foundation: Information on Rare Bleeding Disorders.